Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
This article was originally published in The Rose Sheet
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
You may also be interested in...
Consumers picking products over medical procedures: Medical offices catering to client skin-care needs have seen a "flip" in revenue, with increased sales of skin-care products as well as injectables such as Botox rather than plastic surgery, according to Loretta Ciraldo, professor of dermatology at the University of Miami School of Medicine and principal of Dr. Loretta Skincare. Consumers have less discretionary income, and instead of coming in for a facelift they are opting for products to combat aging, she said Sept. 29 during an HBA Global Expo session entitled "The Future of Skincare: Finding Your Place in a Shifting Market." However, "there's a higher expectation on the part of the consumer" as they look for immediate results from products purchased at medical offices compared to products from traditional retail channels, Ciraldo noted
Increased scrutiny of anti-aging products entering the U.S. presages "a major enforcement initiative" against illegal cosmetic claims that will impact domestic personal-care firms, large and small, according to attorney and ex-FDAer Benjamin L. England
FDA under the new administration may have a sharper eye on cosmeceuticals than it has in years past, according to Georgia C. Ravitz, a food and drug law lawyer at Arendt Fox